Company / Operating Cash Flow per Share
ADMA Biologics, Inc. Operating Cash Flow per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
$0.21
FY2025
5-year range
-$1.07 / $0.52
FY2021-FY2025
Trend
-59.4%
vs FY2024
Sector context
#68 of 212
Health Care
What the data says
At $0.21, ADMA Biologics, Inc.'s operating cash flow per share ranks #68 of 212 in the Health Care sector. Operating Cash Flow per Share has fluctuated over the past 10 years, ranging from $-1.72 in FY2020 to $0.52 in FY2024.
Based on SEC 10-K filings.
0.21 in FY2025.
Improved from $0.04 to $0.21 over the past 2 years.
Health Care sector context is included.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#68 of 212 in Health CareTop 32% of 212This company $0.21 Sector average $5.28
▼
-96.0% below sector average
Key checks
Key Insights
- In FY2025, operating cash flow per share decreased 59.4% year-over-year.
- Ranks #68 out of 212 companies in the Health Care sector.
- Peak operating cash flow per share was recorded in FY2024.
- Lowest operating cash flow per share in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score 3.37 (safe zone, above 2.9 threshold)
- Strong profit margin: 46.4%
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.21 | -59.4% |
| FY2024 | $0.52 | +1223.2% |
| FY2023 | $0.04 | +106.9% |
| FY2022 | -$0.57 | +46.4% |
| FY2021 | -$1.07 | +37.7% |
| FY2020 | -$1.72 | -4.6% |
| FY2019 | -$1.64 | +3.7% |
| FY2018 | -$1.71 | -20.4% |
| FY2017 | -$1.42 | +16.9% |
| FY2016 | -$1.71 | -7.8% |
As of FY2025 · SEC 10-K · Updated Jul 1, 2026